(INNV) InnovAge Holding - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45784A1043
INNV: Medical Services, Home Care, Transportation, Meal Services, Therapy
InnovAge Holding Corp (NASDAQ:INNV) operates as a healthcare services provider specializing in senior care through the Program of All-Inclusive Care for the Elderly (PACE). The company delivers comprehensive medical and non-medical services to enable elderly participants to live independently in their homes or in supported community settings. Its service portfolio includes in-home care (skilled, unskilled, and personal care), in-center services such as primary care, physical therapy, and mental health services, as well as transportation to medical appointments. The company manages PACE centers across six states: Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. Formerly known as TCO Group Holdings, Inc., InnovAge rebranded in January 2021 and has been operational since its founding in 2007. The company is headquartered in Denver, Colorado.
From a financial perspective, InnovAge Holding Corp (NASDAQ:INNV) has a market capitalization of $449.01M USD. The stock currently trades at $3.26, with a 20-day average volume of 63,981 shares. Its price-to-book ratio stands at 1.81, and the forward P/E ratio is 13.66, indicating potential undervaluation relative to future earnings expectations. However, the return on equity (RoE) is -10.04%, reflecting current profitability challenges.
Over the next three months, based on the
Additional Sources for INNV Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
INNV Stock Overview
Market Cap in USD | 403m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2021-03-04 |
INNV Stock Ratings
Growth Rating | -71.9 |
Fundamental | -19.6 |
Dividend Rating | 0.0 |
Rel. Strength | -30.9 |
Analysts | 2.75/5 |
Fair Price Momentum | 2.04 USD |
Fair Price DCF | - |
INNV Dividends
No Dividends PaidINNV Growth Ratios
Growth Correlation 3m | -87.3% |
Growth Correlation 12m | -55.1% |
Growth Correlation 5y | -59.3% |
CAGR 5y | -40.93% |
CAGR/Max DD 5y | -0.46 |
Sharpe Ratio 12m | -0.07 |
Alpha | -36.73 |
Beta | 0.507 |
Volatility | 57.48% |
Current Volume | 40.6k |
Average Volume 20d | 42.5k |
As of April 19, 2025, the stock is trading at USD 2.75 with a total of 40,600 shares traded.
Over the past week, the price has changed by -2.48%, over one month by -21.65%, over three months by -25.68% and over the past year by -31.25%.
Neither. Based on ValueRay Fundamental Analyses, InnovAge Holding is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -19.55 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INNV as of April 2025 is 2.04. This means that INNV is currently overvalued and has a potential downside of -25.82%.
InnovAge Holding has received a consensus analysts rating of 2.75. Therefor, it is recommend to hold INNV.
- Strong Buy: 0
- Buy: 0
- Hold: 3
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, INNV InnovAge Holding will be worth about 2.2 in April 2026. The stock is currently trading at 2.75. This means that the stock has a potential downside of -19.27%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.3 | 90.9% |
Analysts Target Price | 5.5 | 100% |
ValueRay Target Price | 2.2 | -19.3% |